Figure 2. Estimated 2017 Patient Out-of-Pocket Spending for Either Ledipasvir and Sofosbuvir Regimen or Elbasvir and Grazoprevir Regimen.

Data derived from the Medicare Plan Finder for the AARP MedicareRX Saver Plus Part D plan using published methods.^11,12 Prices were obtained in December 2016, excluded monthly premium amounts, and were applicable to patients not receiving extra help or low-income subsidy from Medicaid or Medicare (approximately 70% of patients enrolled in stand-alone Part D plans).